Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Algorhythm Holdings (RIME) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Algorhythm Holdings (RIME) over the last 15 years, with Q3 2025 value amounting to $2.8 million.

  • Algorhythm Holdings' Cash & Equivalents rose 35716.59% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 35716.59%. This contributed to the annual value of $7.2 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Algorhythm Holdings' Cash & Equivalents stood at $2.8 million, which was up 35716.59% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Algorhythm Holdings' Cash & Equivalents ranged from a high of $7.4 million in Q4 2021 and a low of $396579.0 during Q1 2021
  • Moreover, its 5-year median value for Cash & Equivalents was $2.8 million (2022), whereas its average is $2.7 million.
  • Within the past 5 years, the most significant YoY rise in Algorhythm Holdings' Cash & Equivalents was 113430.03% (2024), while the steepest drop was 8067.23% (2024).
  • Algorhythm Holdings' Cash & Equivalents (Quarter) stood at $7.4 million in 2021, then tumbled by 62.1% to $2.8 million in 2022, then tumbled by 79.03% to $586000.0 in 2023, then soared by 1134.3% to $7.2 million in 2024, then tumbled by 60.75% to $2.8 million in 2025.
  • Its Cash & Equivalents was $2.8 million in Q3 2025, compared to $1.1 million in Q2 2025 and $3.3 million in Q1 2025.